The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-World stock markets kick off 2021 at record highs

Mon, 04th Jan 2021 09:09

* MSCI All-Country World Index hits record high

* Bitcoin trades above $32,000

* Yuan surges nearly 1% vs. dollar

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Ritvik Carvalho

LONDON, Jan 4 (Reuters) - World stock markets hit record
highs on Monday, the first trading day of the new year, as
investors hoped the rollout of vaccines would ultimately lift a
global economy decimated by the COVID-19 pandemic.

The Chinese yuan surged nearly 1% against the dollar,
while the greenback plumbed its lowest levels against a basket
of peer currencies since April 2018. Bitcoin hovered
above $32,000 on the back of a blistering 800% rally since
mid-March.

European stocks opened higher, with Britain's FTSE 100
gaining 1.75%, Germany's DAX up 1.1%, Spain's
IBEX up 1.3% and Italy's FTSE MIB rising
0.7%.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, hit a record high and was up nearly
half a percent on the day after the start of trading in London.

"The year kicks off as 2020 ended, an everything rally with
the double V dichotomy (virus vs. vaccine) seeing the hopes that
either things get worse and stimulus ramps up or things get
better and, well, things get better so long as there’s no hint
of liquidity withdrawal and a taper tantrum," a trader said.

Asian stock markets also gained, although Japan's Nikkei 225
index shed early gains, falling 0.4% after Prime
Minister Yoshihide Suga confirmed the government was considering
a state of emergency for Tokyo and three surrounding prefectures
as the coronavirus spreads.

Despite the optimism over vaccines, investors are still
sounding caution over the path of the virus, which continues to
spread amidst the discovery of a new strain.

"The virus retains the upper hand for a while longer," said
Karl Steiner, chief quantiative strategist at SEB, noting that
vaccinations have had an uneven start, characterized by vaccine
shortages, vaccine resistance and delays.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

"We continue to believe that equities have further room to
rise in 2021 as monetary and fiscal stimulus measures provide a
tailwind, and we anticipate significant earnings growth as the
global economy recovers," said Mark Haefele, chief investment
officer at UBS Global Wealth Management.

Minutes of the Federal Reserve's December meeting are due on
Wednesday and should offer more detail on discussions about
making their forward policy guidance more explicit and the
chance of a further increase in asset buying this year.

E-Mini futures for the S&P 500 were steady after also
touching a record high.

PAYROLLS A RISK

The data calendar includes a raft of manufacturing surveys
across the globe, which will show how industry is coping with
the spread of the coronavirus, and the closely watched ISM
surveys of U.S. factories and services.

Chinese factory activity continued to accelerate in
December, though the PMI missed forecasts at 53.0.

Japanese manufacturing stabilised for the first time in two
years in December, while Taiwan picked up.

Friday sees the U.S. December payroll report where median
forecasts are for only a modest increase of 100,000 jobs.

Analysts as Barclays are tipping a fall of 50,000 in jobs,
which would be a shock to market hopes of a speedy recovery.

"A number of incoming indicators on activity point to slower
momentum as the economy closes out the year, including data on
labour markets where initial claims rose during the December
survey period," said economist Michael Gapen in a note.

Such a drop would add pressure on the Fed to ease further,
another burden for the dollar which is already buckling under
the weight of the massive U.S. budget and trade deficits.

In currencies, the euro pushed back up to $1.2281,
having run into profit-taking late last week when it reached the
highest since early 2018 at $1.2309. It gained almost 9% over
2020.

The dollar slipped to 102.80 yen. Sterling firmed to
$1.3690, levels last seen in mid-2018.

The decline in the dollar has been a support for gold,
leaving the metal 1.3% firmer at $1,931 an ounce.

Oil prices extended their rise after a couple of months of
solid gains, with Brent crossing $53 a barrel. U.S. crude
added 2% to $49.52 a barrel.

(Reporting by Ritvik Carvalho; additional reporting by Carolyn
Cohn in London and Wayne Cole in Sydney; Editing by Toby Chopra)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.